340 related articles for article (PubMed ID: 33540856)
1. Microemulsion-Based Media in Nose-to-Brain Drug Delivery.
Froelich A; Osmałek T; Jadach B; Puri V; Michniak-Kohn B
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540856
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery.
Nguyen TT; Maeng HJ
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335948
[TBL] [Abstract][Full Text] [Related]
3. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
4. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
5. [Research progress on traditional Chinese medicine in preventing and treating cerebral ischemia injury based on "nose-brain" pathway].
Wei ZZ; Fang XY; Fan SK; Peng MF; Bai M; Miao MS
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4800-4805. PubMed ID: 31872585
[TBL] [Abstract][Full Text] [Related]
6. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Shinde RL; Bharkad GP; Devarajan PV
Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
[TBL] [Abstract][Full Text] [Related]
7. Intranasal drug delivery for brain targeting.
Vyas TK; Shahiwala A; Marathe S; Misra A
Curr Drug Deliv; 2005 Apr; 2(2):165-75. PubMed ID: 16305417
[TBL] [Abstract][Full Text] [Related]
8. Nanoemulsions for "Nose-to-Brain" Drug Delivery.
Bonferoni MC; Rossi S; Sandri G; Ferrari F; Gavini E; Rassu G; Giunchedi P
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781585
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-brain delivery of antipsychotics using nanotechnology: a review.
Tan MSA; Parekh HS; Pandey P; Siskind DJ; Falconer JR
Expert Opin Drug Deliv; 2020 Jun; 17(6):839-853. PubMed ID: 32343186
[TBL] [Abstract][Full Text] [Related]
10. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
11. Research progress in brain-targeted nasal drug delivery.
Huang Q; Chen X; Yu S; Gong G; Shu H
Front Aging Neurosci; 2023; 15():1341295. PubMed ID: 38298925
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
13. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
14. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies.
Pires PC; Santos AO
J Control Release; 2018 Jan; 270():89-100. PubMed ID: 29199063
[TBL] [Abstract][Full Text] [Related]
15. Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.
Sonvico F; Clementino A; Buttini F; Colombo G; Pescina S; Stanisçuaski Guterres S; Raffin Pohlmann A; Nicoli S
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29543755
[TBL] [Abstract][Full Text] [Related]
16. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
18. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
19. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route.
Pathak R; Dash RP; Misra M; Nivsarkar M
Acta Pharm Sin B; 2014 Apr; 4(2):151-60. PubMed ID: 26579378
[TBL] [Abstract][Full Text] [Related]
20. Recent patents review on intranasal administration for CNS drug delivery.
Jogani V; Jinturkar K; Vyas T; Misra A
Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
